| Symbol |
Name |
|
ABCA4
|
ATP-binding cassette, sub-family A (ABC1), member 4
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC6
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 6
|
|
ABCD1
|
ATP-binding cassette, sub-family D (ALD), member 1
|
|
ABCG1
|
ATP-binding cassette, sub-family G (WHITE), member 1
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACAD9
|
acyl-CoA dehydrogenase family, member 9
|
|
ACADVL
|
acyl-CoA dehydrogenase, very long chain
|
|
ACAN
|
aggrecan
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACP5
|
acid phosphatase 5, tartrate resistant
|
|
ACVRL1
|
activin A receptor type II-like 1
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADAR
|
adenosine deaminase, RNA-specific
|
|
ADCK3
|
aarF domain containing kinase 3
|
|
ADCYAP1
|
adenylate cyclase activating polypeptide 1 (pituitary)
|
|
ADGRE1
|
adhesion G protein-coupled receptor E1
|
|
ADGRE3
|
adhesion G protein-coupled receptor E3
|
|
ADH1A
|
alcohol dehydrogenase 1A (class I), alpha polypeptide
|
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
|
ADH1C
|
alcohol dehydrogenase 1C (class I), gamma polypeptide
|
|
ADH4
|
alcohol dehydrogenase 4 (class II), pi polypeptide
|
|
ADH7
|
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPQTL2
|
Circulating adiponectin QTL on chromosome 5
|
|
ADM
|
adrenomedullin
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AGA
|
aspartylglucosaminidase
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AGRN
|
agrin
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AHCYL1
|
adenosylhomocysteinase-like 1
|
|
AHI1
|
Abelson helper integration site 1
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
|
AKR1B10
|
aldo-keto reductase family 1, member B10 (aldose reductase)
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALAS1
|
5'-aminolevulinate synthase 1
|
|
ALB
|
albumin
|
|
ALDH18A1
|
aldehyde dehydrogenase 18 family, member A1
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ALOX5AP
|
arachidonate 5-lipoxygenase-activating protein
|
|
AMOTL1
|
angiomotin like 1
|
|
ANAPC7
|
anaphase promoting complex subunit 7
|
|
ANGPT2
|
angiopoietin 2
|
|
ANK1
|
ankyrin 1, erythrocytic
|
|
ANLN
|
anillin, actin binding protein
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
|
ANXA5
|
annexin A5
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA5
|
apolipoprotein A-V
|
|
APOB
|
apolipoprotein B
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOC1
|
apolipoprotein C-I
|
|
APOC3
|
apolipoprotein C-III
|
|
APOE
|
apolipoprotein E
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
APOL1
|
apolipoprotein L, 1
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
|
AQP3
|
aquaporin 3 (Gill blood group)
|
|
AQP4
|
aquaporin 4
|
|
AR
|
androgen receptor
|
|
ARHGEF6
|
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6
|
|
ARID3C
|
AT rich interactive domain 3C (BRIGHT-like)
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
ASXL1
|
additional sex combs like transcriptional regulator 1
|
|
ATF4
|
activating transcription factor 4
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP13A2
|
ATPase type 13A2
|
|
ATP1A1
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide
|
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
|
ATP1B2
|
ATPase, Na+/K+ transporting, beta 2 polypeptide
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
AVP
|
arginine vasopressin
|
|
AZF1
|
azoospermia factor 1
|
|
B3GAT1
|
beta-1,3-glucuronyltransferase 1
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCR
|
breakpoint cluster region
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BLM
|
Bloom syndrome, RecQ helicase-like
|
|
BMP1
|
bone morphogenetic protein 1
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRD2
|
bromodomain containing 2
|
|
BRD4
|
bromodomain containing 4
|
|
BSG
|
basigin (Ok blood group)
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
BUB3
|
BUB3 mitotic checkpoint protein
|
|
C1QA
|
complement component 1, q subcomponent, A chain
|
|
C1QB
|
complement component 1, q subcomponent, B chain
|
|
C3
|
complement component 3
|
|
C5AR1
|
complement component 5a receptor 1
|
|
C9ORF24
|
chromosome 9 open reading frame 24
|
|
C9ORF72
|
chromosome 9 open reading frame 72
|
|
CABIN1
|
calcineurin binding protein 1
|
|
CACNA1B
|
calcium channel, voltage-dependent, N type, alpha 1B subunit
|
|
CALB2
|
calbindin 2
|
|
CAPN7
|
calpain 7
|
|
CARD11
|
caspase recruitment domain family, member 11
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASP2
|
caspase 2, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CBFA2T3
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 3
|
|
CBLB
|
Cbl proto-oncogene B, E3 ubiquitin protein ligase
|
|
CCDC28A
|
coiled-coil domain containing 28A
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCND1
|
cyclin D1
|
|
CCNE1
|
cyclin E1
|
|
CCNK
|
cyclin K
|
|
CD160
|
CD160 molecule
|
|
CD1A
|
CD1a molecule
|
|
CD200
|
CD200 molecule
|
|
CD209
|
CD209 molecule
|
|
CD4
|
CD4 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD58
|
CD58 molecule
|
|
CD81
|
CD81 molecule
|
|
CDC20
|
cell division cycle 20
|
|
CDC25C
|
cell division cycle 25C
|
|
CDC27
|
cell division cycle 27
|
|
CDC73
|
cell division cycle 73
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH13
|
cadherin 13
|
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental)
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDX2
|
caudal type homeobox 2
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CEP57
|
centrosomal protein 57kDa
|
|
CERS5
|
ceramide synthase 5
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFH
|
complement factor H
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFP
|
complement factor properdin
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHD7
|
chromodomain helicase DNA binding protein 7
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHGA
|
chromogranin A
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CHL1
|
cell adhesion molecule L1-like
|
|
CHRM2
|
cholinergic receptor, muscarinic 2
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal)
|
|
CHRNA5
|
cholinergic receptor, nicotinic, alpha 5 (neuronal)
|
|
CHRNB4
|
cholinergic receptor, nicotinic, beta 4 (neuronal)
|
|
CIB1
|
calcium and integrin binding 1 (calmyrin)
|
|
CIC
|
capicua transcriptional repressor
|
|
CLDN4
|
claudin 4
|
|
CLDN6
|
claudin 6
|
|
CLSPN
|
claspin
|
|
CLU
|
clusterin
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNTN4
|
contactin 4
|
|
COL17A1
|
collagen, type XVII, alpha 1
|
|
COL4A3BP
|
collagen, type IV, alpha 3 (Goodpasture antigen) binding protein
|
|
COL5A1
|
collagen, type V, alpha 1
|
|
COL6A4P1
|
collagen, type VI, alpha 4 pseudogene 1
|
|
COL6A4P2
|
collagen, type VI, alpha 4 pseudogene 2
|
|
COL6A5
|
collagen, type VI, alpha 5
|
|
COL6A6
|
collagen, type VI, alpha 6
|
|
COL7A1
|
collagen, type VII, alpha 1
|
|
COMP
|
cartilage oligomeric matrix protein
|
|
COMT
|
catechol-O-methyltransferase
|
|
CPOX
|
coproporphyrinogen oxidase
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREBBP
|
CREB binding protein
|
|
CREM
|
cAMP responsive element modulator
|
|
CRISP2
|
cysteine-rich secretory protein 2
|
|
CRISP3
|
cysteine-rich secretory protein 3
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRTAP
|
cartilage associated protein
|
|
CRTC2
|
CREB regulated transcription coactivator 2
|
|
CRX
|
cone-rod homeobox
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CST3
|
cystatin C
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
|
CTSS
|
cathepsin S
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL16
|
chemokine (C-X-C motif) ligand 16
|
|
CXCL2
|
chemokine (C-X-C motif) ligand 2
|
|
CXCL6
|
chemokine (C-X-C motif) ligand 6
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXCR5
|
chemokine (C-X-C motif) receptor 5
|
|
CYCS
|
cytochrome c, somatic
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP11B1
|
cytochrome P450, family 11, subfamily B, polypeptide 1
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
DAXX
|
death-domain associated protein
|
|
DAZ1
|
deleted in azoospermia 1
|
|
DBH
|
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
|
|
DCBLD2
|
discoidin, CUB and LCCL domain containing 2
|
|
DCN
|
decorin
|
|
DCXR
|
dicarbonyl/L-xylulose reductase
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DDR1
|
discoidin domain receptor tyrosine kinase 1
|
|
DDX41
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 41
|
|
DEFB4A
|
defensin, beta 4A
|
|
DEL22Q11.2
|
Chromosome 22q11.2 deletion syndrome, distal
|
|
DFNB33
|
deafness, autosomal recessive 33
|
|
DHX32
|
DEAH (Asp-Glu-Ala-His) box polypeptide 32
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DLX3
|
distal-less homeobox 3
|
|
DLX5
|
distal-less homeobox 5
|
|
DMD
|
dystrophin
|
|
DMPK
|
dystrophia myotonica-protein kinase
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNTT
|
DNA nucleotidylexotransferase
|
|
DPP10
|
dipeptidyl-peptidase 10 (non-functional)
|
|
DPP6
|
dipeptidyl-peptidase 6
|
|
DRD2
|
dopamine receptor D2
|
|
DRD4
|
dopamine receptor D4
|
|
DRD5
|
dopamine receptor D5
|
|
DSC3
|
desmocollin 3
|
|
DST
|
dystonin
|
|
DTNBP1
|
dystrobrevin binding protein 1
|
|
DTX3L
|
deltex 3 like, E3 ubiquitin ligase
|
|
DUX4L1
|
double homeobox 4 like 1
|
|
DYNLL1
|
dynein, light chain, LC8-type 1
|
|
DYX1C1
|
dyslexia susceptibility 1 candidate 1
|
|
E2F1
|
E2F transcription factor 1
|
|
EDN1
|
endothelin 1
|
|
EDNRA
|
endothelin receptor type A
|
|
EDNRB
|
endothelin receptor type B
|
|
EFTUD2
|
elongation factor Tu GTP binding domain containing 2
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
|
EIF2AK3
|
eukaryotic translation initiation factor 2-alpha kinase 3
|
|
EIF4A3
|
eukaryotic translation initiation factor 4A3
|
|
EIF4B
|
eukaryotic translation initiation factor 4B
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
EIF4H
|
eukaryotic translation initiation factor 4H
|
|
ELAC2
|
elaC ribonuclease Z 2
|
|
ELAVL2
|
ELAV like neuron-specific RNA binding protein 2
|
|
ELN
|
elastin
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
|
ENPEP
|
glutamyl aminopeptidase (aminopeptidase A)
|
|
EP300
|
E1A binding protein p300
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHB4
|
EPH receptor B4
|
|
EPHX2
|
epoxide hydrolase 2, cytoplasmic
|
|
EPM2A
|
epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)
|
|
EPO
|
erythropoietin
|
|
EPOR
|
erythropoietin receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC3
|
excision repair cross-complementation group 3
|
|
ERCC4
|
excision repair cross-complementation group 4
|
|
ERCC6
|
excision repair cross-complementation group 6
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ERLIN1
|
ER lipid raft associated 1
|
|
ERLIN2
|
ER lipid raft associated 2
|
|
ERO1L
|
ERO1-like (S. cerevisiae)
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETV6
|
ets variant 6
|
|
EXOSC10
|
exosome component 10
|
|
EXT1
|
exostosin glycosyltransferase 1
|
|
EXT2
|
exostosin glycosyltransferase 2
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
EZR
|
ezrin
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
F9
|
coagulation factor IX
|
|
FABP3
|
fatty acid binding protein 3, muscle and heart
|
|
FAM126A
|
family with sequence similarity 126, member A
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FAS
|
Fas cell surface death receptor
|
|
FAT4
|
FAT atypical cadherin 4
|
|
FBN1
|
fibrillin 1
|
|
FBXO11
|
F-box protein 11
|
|
FBXO7
|
F-box protein 7
|
|
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64)
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FCGR2C
|
Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FERMT2
|
fermitin family member 2
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FHIT
|
fragile histidine triad
|
|
FHL3
|
four and a half LIM domains 3
|
|
FLNA
|
filamin A, alpha
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FLVCR1
|
feline leukemia virus subgroup C cellular receptor 1
|
|
FMO3
|
flavin containing monooxygenase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FN1
|
fibronectin 1
|
|
FN3K
|
fructosamine 3 kinase
|
|
FOXA1
|
forkhead box A1
|
|
FOXF1
|
forkhead box F1
|
|
FOXM1
|
forkhead box M1
|
|
FOXO3
|
forkhead box O3
|
|
FOXP1
|
forkhead box P1
|
|
FOXP2
|
forkhead box P2
|
|
FOXP3
|
forkhead box P3
|
|
FPR1
|
formyl peptide receptor 1
|
|
FRAS1
|
Fraser extracellular matrix complex subunit 1
|
|
FREM2
|
FRAS1 related extracellular matrix protein 2
|
|
FRMD7
|
FERM domain containing 7
|
|
FTO
|
fat mass and obesity associated
|
|
FUBP1
|
far upstream element (FUSE) binding protein 1
|
|
FUS
|
FUS RNA binding protein
|
|
GAA
|
glucosidase, alpha; acid
|
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3
|
|
GALNT12
|
polypeptide N-acetylgalactosaminyltransferase 12
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA2
|
GATA binding protein 2
|
|
GATA4
|
GATA binding protein 4
|
|
GCG
|
glucagon
|
|
GCH1
|
GTP cyclohydrolase 1
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GDF15
|
growth differentiation factor 15
|
|
GEMIN5
|
gem (nuclear organelle) associated protein 5
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GGT1
|
gamma-glutamyltransferase 1
|
|
GH1
|
growth hormone 1
|
|
GHR
|
growth hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GIP
|
gastric inhibitory polypeptide
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GLA
|
galactosidase, alpha
|
|
GLRX2
|
glutaredoxin 2
|
|
GLUD1
|
glutamate dehydrogenase 1
|
|
GLUD2
|
glutamate dehydrogenase 2
|
|
GNAI1
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1
|
|
GNAS
|
GNAS complex locus
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GNB4
|
guanine nucleotide binding protein (G protein), beta polypeptide 4
|
|
GNRHR
|
gonadotropin-releasing hormone receptor
|
|
GP6
|
glycoprotein VI (platelet)
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
|
GPR132
|
G protein-coupled receptor 132
|
|
GPR179
|
G protein-coupled receptor 179
|
|
GPR83
|
G protein-coupled receptor 83
|
|
GPSM1
|
G-protein signaling modulator 1
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GREB1
|
growth regulation by estrogen in breast cancer 1
|
|
GRID2
|
glutamate receptor, ionotropic, delta 2
|
|
GRM7
|
glutamate receptor, metabotropic 7
|
|
GRN
|
granulin
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GTF2I
|
general transcription factor IIi
|
|
GUCA1A
|
guanylate cyclase activator 1A (retina)
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HAX1
|
HCLS1 associated protein X-1
|
|
HBD
|
hemoglobin, delta
|
|
HERC2
|
HECT and RLD domain containing E3 ubiquitin protein ligase 2
|
|
HFE
|
hemochromatosis
|
|
HFE2
|
hemochromatosis type 2 (juvenile)
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIF1AN
|
hypoxia inducible factor 1, alpha subunit inhibitor
|
|
HIST4H4
|
histone cluster 4, H4
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HLCS
|
holocarboxylase synthetase (biotin-(proprionyl-CoA-carboxylase (ATP-hydrolysing)) ligase)
|
|
HMGCR
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
|
HMMR
|
hyaluronan-mediated motility receptor (RHAMM)
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF1B
|
HNF1 homeobox B
|
|
HNRNPD
|
heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa)
|
|
HOXA13
|
homeobox A13
|
|
HOXD13
|
homeobox D13
|
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD)
|
|
HRH3
|
histamine receptor H3
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2
|
|
HSD17B10
|
hydroxysteroid (17-beta) dehydrogenase 10
|
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2
|
|
HSP90B1
|
heat shock protein 90kDa beta (Grp94), member 1
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPA9
|
heat shock 70kDa protein 9 (mortalin)
|
|
HSPB6
|
heat shock protein, alpha-crystallin-related, B6
|
|
HSPG2
|
heparan sulfate proteoglycan 2
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
HTR1B
|
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
|
HTR3E
|
5-hydroxytryptamine (serotonin) receptor 3E, ionotropic
|
|
HTT
|
huntingtin
|
|
IBA57
|
IBA57, iron-sulfur cluster assembly homolog (S. cerevisiae)
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICAM3
|
intercellular adhesion molecule 3
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IFNL1
|
interferon, lambda 1
|
|
IFNL2
|
interferon, lambda 2
|
|
IFNL3
|
interferon, lambda 3
|
|
IFNW1
|
interferon, omega 1
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGSF1
|
immunoglobulin superfamily, member 1
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IKZF3
|
IKAROS family zinc finger 3 (Aiolos)
|
|
IL10
|
interleukin 10
|
|
IL16
|
interleukin 16
|
|
IL17A
|
interleukin 17A
|
|
IL17RD
|
interleukin 17 receptor D
|
|
IL1B
|
interleukin 1, beta
|
|
IL1R1
|
interleukin 1 receptor, type I
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL21
|
interleukin 21
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL2RB
|
interleukin 2 receptor, beta
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IMPAD1
|
inositol monophosphatase domain containing 1
|
|
INA
|
internexin neuronal intermediate filament protein, alpha
|
|
INF2
|
inverted formin, FH2 and WH2 domain containing
|
|
INO80
|
INO80 complex subunit
|
|
INPPL1
|
inositol polyphosphate phosphatase-like 1
|
|
INS
|
insulin
|
|
INSL3
|
insulin-like 3 (Leydig cell)
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRF7
|
interferon regulatory factor 7
|
|
IRF8
|
interferon regulatory factor 8
|
|
IRS2
|
insulin receptor substrate 2
|
|
ITCH
|
itchy E3 ubiquitin protein ligase
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB4
|
integrin, beta 4
|
|
ITPR2
|
inositol 1,4,5-trisphosphate receptor, type 2
|
|
JAK2
|
Janus kinase 2
|
|
JMJD6
|
jumonji domain containing 6
|
|
JUN
|
jun proto-oncogene
|
|
KANK1
|
KN motif and ankyrin repeat domains 1
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
KAT5
|
K(lysine) acetyltransferase 5
|
|
KAT8
|
K(lysine) acetyltransferase 8
|
|
KCNC3
|
potassium channel, voltage gated Shaw related subfamily C, member 3
|
|
KCND2
|
potassium channel, voltage gated Shal related subfamily D, member 2
|
|
KCNH1
|
potassium channel, voltage gated eag related subfamily H, member 1
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNIP3
|
Kv channel interacting protein 3, calsenilin
|
|
KCNK9
|
potassium channel, two pore domain subfamily K, member 9
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
|
KCTD9
|
potassium channel tetramerization domain containing 9
|
|
KDR
|
kinase insert domain receptor
|
|
KIAA0319
|
KIAA0319
|
|
KIF5B
|
kinesin family member 5B
|
|
KIR2DS2
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KLB
|
klotho beta
|
|
KLF6
|
Kruppel-like factor 6
|
|
KLK2
|
kallikrein-related peptidase 2
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLK6
|
kallikrein-related peptidase 6
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRIT1
|
KRIT1, ankyrin repeat containing
|
|
KRT19
|
keratin 19, type I
|
|
KRT5
|
keratin 5, type II
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
LAMP1
|
lysosomal-associated membrane protein 1
|
|
LAMP2
|
lysosomal-associated membrane protein 2
|
|
LAMP3
|
lysosomal-associated membrane protein 3
|
|
LAMTOR4
|
late endosomal/lysosomal adaptor, MAPK and MTOR activator 4
|
|
LAMTOR5
|
late endosomal/lysosomal adaptor, MAPK and MTOR activator 5
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LCN2
|
lipocalin 2
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LEP
|
leptin
|
|
LETM1
|
leucine zipper-EF-hand containing transmembrane protein 1
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGALS9
|
lectin, galactoside-binding, soluble, 9
|
|
LGALSL
|
lectin, galactoside-binding-like
|
|
LGI4
|
leucine-rich repeat LGI family, member 4
|
|
LINC-PINT
|
long intergenic non-protein coding RNA, p53 induced transcript
|
|
LMNB2
|
lamin B2
|
|
LMX1B
|
LIM homeobox transcription factor 1, beta
|
|
LOXL1
|
lysyl oxidase-like 1
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LPP
|
LIM domain containing preferred translocation partner in lipoma
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LTB
|
lymphotoxin beta (TNF superfamily, member 3)
|
|
LTF
|
lactotransferrin
|
|
LYZ
|
lysozyme
|
|
MAN1B1
|
mannosidase, alpha, class 1B, member 1
|
|
MAOA
|
monoamine oxidase A
|
|
MAOB
|
monoamine oxidase B
|
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8IP1
|
mitogen-activated protein kinase 8 interacting protein 1
|
|
MAPT
|
microtubule-associated protein tau
|
|
MATN3
|
matrilin 3
|
|
MBD1
|
methyl-CpG binding domain protein 1
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MEF2C
|
myocyte enhancer factor 2C
|
|
MEFV
|
Mediterranean fever
|
|
MFSD2A
|
major facilitator superfamily domain containing 2A
|
|
MFSD2B
|
major facilitator superfamily domain containing 2B
|
|
MGAT3
|
mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase
|
|
MGAT5
|
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR122
|
microRNA 122
|
|
MIR137
|
microRNA 137
|
|
MIR221
|
microRNA 221
|
|
MIR222
|
microRNA 222
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLXIP
|
MLX interacting protein
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMEL1
|
membrane metallo-endopeptidase-like 1
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MOCS3
|
molybdenum cofactor synthesis 3
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MSTN
|
myostatin
|
|
MT-ATP6
|
ATP synthase F0 subunit 6
|
|
MT-ND3
|
NADH dehydrogenase, subunit 3 (complex I)
|
|
MT-ND4
|
NADH dehydrogenase, subunit 4 (complex I)
|
|
MTA1
|
metastasis associated 1
|
|
MTERF1
|
mitochondrial transcription termination factor 1
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MUC5B
|
mucin 5B, oligomeric mucus/gel-forming
|
|
MUTYH
|
mutY homolog
|
|
MVK
|
mevalonate kinase
|
|
MXI1
|
MAX interactor 1, dimerization protein
|
|
MXRA5
|
matrix-remodelling associated 5
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYH7
|
myosin, heavy chain 7, cardiac muscle, beta
|
|
MYO1C
|
myosin IC
|
|
MYO1F
|
myosin IF
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
|
MZF1
|
myeloid zinc finger 1
|
|
NAT1
|
N-acetyltransferase 1 (arylamine N-acetyltransferase)
|
|
NBN
|
nibrin
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCF2
|
neutrophil cytosolic factor 2
|
|
NDE1
|
nudE neurodevelopment protein 1
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NDUFA1
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa
|
|
NEFH
|
neurofilament, heavy polypeptide
|
|
NEFL
|
neurofilament, light polypeptide
|
|
NEFM
|
neurofilament, medium polypeptide
|
|
NEUROD1
|
neuronal differentiation 1
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF1
|
neurofibromin 1
|
|
NFASC
|
neurofascin
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
|
NFKBIZ
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta
|
|
NHLRC1
|
NHL repeat containing E3 ubiquitin protein ligase 1
|
|
NIPBL
|
Nipped-B homolog (Drosophila)
|
|
NKX2-5
|
NK2 homeobox 5
|
|
NOD1
|
nucleotide-binding oligomerization domain containing 1
|
|
NOG
|
noggin
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS1AP
|
nitric oxide synthase 1 (neuronal) adaptor protein
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NPC1
|
Niemann-Pick disease, type C1
|
|
NPPB
|
natriuretic peptide B
|
|
NPPC
|
natriuretic peptide C
|
|
NPY2R
|
neuropeptide Y receptor Y2
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRF1
|
nuclear respiratory factor 1
|
|
NRG1
|
neuregulin 1
|
|
NRIP1
|
nuclear receptor interacting protein 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NUP98
|
nucleoporin 98kDa
|
|
NUSAP1
|
nucleolar and spindle associated protein 1
|
|
OCA2
|
oculocutaneous albinism II
|
|
OPA1
|
optic atrophy 1 (autosomal dominant)
|
|
OPTN
|
optineurin
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
OTX2
|
orthodenticle homeobox 2
|
|
P3H1
|
prolyl 3-hydroxylase 1
|
|
PABPN1
|
poly(A) binding protein, nuclear 1
|
|
PAEP
|
progestagen-associated endometrial protein
|
|
PALB2
|
partner and localizer of BRCA2
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARK7
|
parkinson protein 7
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PATE1
|
prostate and testis expressed 1
|
|
PATE2
|
prostate and testis expressed 2
|
|
PATE3
|
prostate and testis expressed 3
|
|
PATE4
|
prostate and testis expressed 4
|
|
PAX8
|
paired box 8
|
|
PCA3
|
prostate cancer associated 3 (non-protein coding)
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PCSK9
|
proprotein convertase subtilisin/kexin type 9
|
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDHX
|
pyruvate dehydrogenase complex, component X
|
|
PDIA2
|
protein disulfide isomerase family A, member 2
|
|
PDK1
|
pyruvate dehydrogenase kinase, isozyme 1
|
|
PDPN
|
podoplanin
|
|
PDX1
|
pancreatic and duodenal homeobox 1
|
|
PDYN
|
prodynorphin
|
|
PDZK1
|
PDZ domain containing 1
|
|
PEAR1
|
platelet endothelial aggregation receptor 1
|
|
PER1
|
period circadian clock 1
|
|
PEX19
|
peroxisomal biogenesis factor 19
|
|
PGAM1
|
phosphoglycerate mutase 1 (brain)
|
|
PGR
|
progesterone receptor
|
|
PHF2
|
PHD finger protein 2
|
|
PHF6
|
PHD finger protein 6
|
|
PICALM
|
phosphatidylinositol binding clathrin assembly protein
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PKM
|
pyruvate kinase, muscle
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLA2G2D
|
phospholipase A2, group IID
|
|
PLA2G4D
|
phospholipase A2, group IVD (cytosolic)
|
|
PLA2G6
|
phospholipase A2, group VI (cytosolic, calcium-independent)
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLG
|
plasminogen
|
|
PMCH
|
pro-melanin-concentrating hormone
|
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
POC1A
|
POC1 centriolar protein A
|
|
POC1B
|
POC1 centriolar protein B
|
|
POLE
|
polymerase (DNA directed), epsilon, catalytic subunit
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
POLL
|
polymerase (DNA directed), lambda
|
|
POLR2M
|
polymerase (RNA) II (DNA directed) polypeptide M
|
|
PON1
|
paraoxonase 1
|
|
POR
|
P450 (cytochrome) oxidoreductase
|
|
POT1
|
protection of telomeres 1
|
|
POU3F4
|
POU class 3 homeobox 4
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPBP
|
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)
|
|
PPIB
|
peptidylprolyl isomerase B (cyclophilin B)
|
|
PPIL1
|
peptidylprolyl isomerase (cyclophilin)-like 1
|
|
PPM1A
|
protein phosphatase, Mg2+/Mn2+ dependent, 1A
|
|
PPP3CB
|
protein phosphatase 3, catalytic subunit, beta isozyme
|
|
PPP3R2
|
protein phosphatase 3, regulatory subunit B, beta
|
|
PRCP
|
prolylcarboxypeptidase (angiotensinase C)
|
|
PRDM2
|
PR domain containing 2, with ZNF domain
|
|
PRDX6
|
peroxiredoxin 6
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCH
|
protein kinase C, eta
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKD2
|
protein kinase D2
|
|
PRKD3
|
protein kinase D3
|
|
PRL
|
prolactin
|
|
PRND
|
prion protein 2 (dublet)
|
|
PRNP
|
prion protein
|
|
PROS1
|
protein S (alpha)
|
|
PROX1
|
prospero homeobox 1
|
|
PROZ
|
protein Z, vitamin K-dependent plasma glycoprotein
|
|
PRPF19
|
pre-mRNA processing factor 19
|
|
PRPH2
|
peripherin 2 (retinal degeneration, slow)
|
|
PRPS1
|
phosphoribosyl pyrophosphate synthetase 1
|
|
PSENEN
|
presenilin enhancer gamma secretase subunit
|
|
PSIP1
|
PC4 and SFRS1 interacting protein 1
|
|
PSMB8
|
proteasome (prosome, macropain) subunit, beta type, 8
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN12
|
protein tyrosine phosphatase, non-receptor type 12
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPRA
|
protein tyrosine phosphatase, receptor type, A
|
|
PTX3
|
pentraxin 3, long
|
|
RAB7A
|
RAB7A, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD51D
|
RAD51 paralog D
|
|
RAMP3
|
receptor (G protein-coupled) activity modifying protein 3
|
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3
|
|
RAPGEF4
|
Rap guanine nucleotide exchange factor (GEF) 4
|
|
RASGRF2
|
Ras protein-specific guanine nucleotide-releasing factor 2
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RAX
|
retina and anterior neural fold homeobox
|
|
RB1
|
retinoblastoma 1
|
|
REG1B
|
regenerating islet-derived 1 beta
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
RFWD2
|
ring finger and WD repeat domain 2, E3 ubiquitin protein ligase
|
|
RGMA
|
repulsive guidance molecule family member a
|
|
RHOB
|
ras homolog family member B
|
|
RHOF
|
ras homolog family member F (in filopodia)
|
|
RIN2
|
Ras and Rab interactor 2
|
|
RLBP1
|
retinaldehyde binding protein 1
|
|
RNR2
|
RNA, ribosomal cluster 2
|
|
ROM1
|
retinal outer segment membrane protein 1
|
|
ROR2
|
receptor tyrosine kinase-like orphan receptor 2
|
|
ROS1
|
ROS proto-oncogene 1 , receptor tyrosine kinase
|
|
RPGR
|
retinitis pigmentosa GTPase regulator
|
|
RPS3
|
ribosomal protein S3
|
|
RS1
|
retinoschisin 1
|
|
RTN4R
|
reticulon 4 receptor
|
|
RUMY1
|
regulator of UNG2 and MKLN1 interacting yippee protein 1
|
|
RUMY2
|
RUMY family member 2
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
RXFP1
|
relaxin/insulin-like family peptide receptor 1
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S100B
|
S100 calcium binding protein B
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
S1PR3
|
sphingosine-1-phosphate receptor 3
|
|
SAE1
|
SUMO1 activating enzyme subunit 1
|
|
SAMHD1
|
SAM domain and HD domain 1
|
|
SART3
|
squamous cell carcinoma antigen recognized by T cells 3
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
|
SDC1
|
syndecan 1
|
|
SDC4
|
syndecan 4
|
|
SDHA
|
succinate dehydrogenase complex, subunit A, flavoprotein (Fp)
|
|
SDS
|
serine dehydratase
|
|
SELPLG
|
selectin P ligand
|
|
SEPT9
|
septin 9
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINB8
|
serpin peptidase inhibitor, clade B (ovalbumin), member 8
|
|
SERPINB9
|
serpin peptidase inhibitor, clade B (ovalbumin), member 9
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF2
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
|
SETD7
|
SET domain containing (lysine methyltransferase) 7
|
|
SEZ6L
|
seizure related 6 homolog (mouse)-like
|
|
SGCE
|
sarcoglycan, epsilon
|
|
SHARPIN
|
SHANK-associated RH domain interactor
|
|
SHBG
|
sex hormone-binding globulin
|
|
SHC3
|
SHC (Src homology 2 domain containing) transforming protein 3
|
|
SHOX
|
short stature homeobox
|
|
SHOX2
|
short stature homeobox 2
|
|
SIGLEC8
|
sialic acid binding Ig-like lectin 8
|
|
SIRT1
|
sirtuin 1
|
|
SKI
|
SKI proto-oncogene
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC11A1
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1
|
|
SLC13A5
|
solute carrier family 13 (sodium-dependent citrate transporter), member 5
|
|
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1
|
|
SLC1A1
|
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1
|
|
SLC22A4
|
solute carrier family 22 (organic cation/zwitterion transporter), member 4
|
|
SLC25A15
|
solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 15
|
|
SLC26A3
|
solute carrier family 26 (anion exchanger), member 3
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A2
|
solute carrier family 2 (facilitated glucose transporter), member 2
|
|
SLC30A8
|
solute carrier family 30 (zinc transporter), member 8
|
|
SLC31A1
|
solute carrier family 31 (copper transporter), member 1
|
|
SLC3A2
|
solute carrier family 3 (amino acid transporter heavy chain), member 2
|
|
SLC45A2
|
solute carrier family 45, member 2
|
|
SLC4A11
|
solute carrier family 4, sodium borate transporter, member 11
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC9A3R1
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1
|
|
SLC9A9
|
solute carrier family 9, subfamily A (NHE9, cation proton antiporter 9), member 9
|
|
SLPI
|
secretory leukocyte peptidase inhibitor
|
|
SMAD4
|
SMAD family member 4
|
|
SMAD7
|
SMAD family member 7
|
|
SMC1A
|
structural maintenance of chromosomes 1A
|
|
SMC3
|
structural maintenance of chromosomes 3
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNRPB
|
small nuclear ribonucleoprotein polypeptides B and B1
|
|
SNW1
|
SNW domain containing 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
|
SOX3
|
SRY (sex determining region Y)-box 3
|
|
SP1
|
Sp1 transcription factor
|
|
SPAG11B
|
sperm associated antigen 11B
|
|
SPG7
|
spastic paraplegia 7 (pure and complicated autosomal recessive)
|
|
SPN
|
sialophorin
|
|
SPTBN2
|
spectrin, beta, non-erythrocytic 2
|
|
SRA1
|
steroid receptor RNA activator 1
|
|
SRCAP
|
Snf2-related CREBBP activator protein
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SRR
|
serine racemase
|
|
SRSF1
|
serine/arginine-rich splicing factor 1
|
|
SRSF3
|
serine/arginine-rich splicing factor 3
|
|
SSTR2
|
somatostatin receptor 2
|
|
STAT2
|
signal transducer and activator of transcription 2, 113kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STIM1
|
stromal interaction molecule 1
|
|
STK39
|
serine threonine kinase 39
|
|
STX11
|
syntaxin 11
|
|
SULT1A1
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1
|
|
SULT1E1
|
sulfotransferase family 1E, estrogen-preferring, member 1
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
SUMO4
|
small ubiquitin-like modifier 4
|
|
SYCN
|
syncollin
|
|
SYK
|
spleen tyrosine kinase
|
|
SYN1
|
synapsin I
|
|
SYP
|
synaptophysin
|
|
T
|
T, brachyury homolog (mouse)
|
|
TAC1
|
tachykinin, precursor 1
|
|
TAC3
|
tachykinin 3
|
|
TAF15
|
TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa
|
|
TAS2R38
|
taste receptor, type 2, member 38
|
|
TBK1
|
TANK-binding kinase 1
|
|
TBX3
|
T-box 3
|
|
TBXA2R
|
thromboxane A2 receptor
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TERC
|
telomerase RNA component
|
|
TERF2
|
telomeric repeat binding factor 2
|
|
TERT
|
telomerase reverse transcriptase
|
|
TES
|
testin LIM domain protein
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TFAP2C
|
transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma)
|
|
TFPI2
|
tissue factor pathway inhibitor 2
|
|
TFRC
|
transferrin receptor
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGIF1
|
TGFB-induced factor homeobox 1
|
|
TGM2
|
transglutaminase 2
|
|
THAP1
|
THAP domain containing, apoptosis associated protein 1
|
|
THBD
|
thrombomodulin
|
|
THBS1
|
thrombospondin 1
|
|
THY1
|
Thy-1 cell surface antigen
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TINF2
|
TERF1 (TRF1)-interacting nuclear factor 2
|
|
TIRAP
|
toll-interleukin 1 receptor (TIR) domain containing adaptor protein
|
|
TLN1
|
talin 1
|
|
TLR4
|
toll-like receptor 4
|
|
TLX1
|
T-cell leukemia homeobox 1
|
|
TMEM173
|
transmembrane protein 173
|
|
TMEM39A
|
transmembrane protein 39A
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TMPRSS6
|
transmembrane protease, serine 6
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF10C
|
tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain
|
|
TNFRSF10D
|
tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TP53BP1
|
tumor protein p53 binding protein 1
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TREM1
|
triggering receptor expressed on myeloid cells 1
|
|
TREX1
|
three prime repair exonuclease 1
|
|
TRIM5
|
tripartite motif containing 5
|
|
TRIT1
|
tRNA isopentenyltransferase 1
|
|
TRMU
|
tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
|
TRPM5
|
transient receptor potential cation channel, subfamily M, member 5
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
|
TRPV3
|
transient receptor potential cation channel, subfamily V, member 3
|
|
TRPV5
|
transient receptor potential cation channel, subfamily V, member 5
|
|
TRPV6
|
transient receptor potential cation channel, subfamily V, member 6
|
|
TRRAP
|
transformation/transcription domain-associated protein
|
|
TSC1
|
tuberous sclerosis 1
|
|
TTR
|
transthyretin
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
UBA2
|
ubiquitin-like modifier activating enzyme 2
|
|
UBE2I
|
ubiquitin-conjugating enzyme E2I
|
|
UBR5
|
ubiquitin protein ligase E3 component n-recognin 5
|
|
UBXN6
|
UBX domain protein 6
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UGT1A7
|
UDP glucuronosyltransferase 1 family, polypeptide A7
|
|
UGT1A9
|
UDP glucuronosyltransferase 1 family, polypeptide A9
|
|
UMOD
|
uromodulin
|
|
UMPS
|
uridine monophosphate synthetase
|
|
UNG
|
uracil-DNA glycosylase
|
|
USH2A
|
Usher syndrome 2A (autosomal recessive, mild)
|
|
USP7
|
ubiquitin specific peptidase 7 (herpes virus-associated)
|
|
VANGL2
|
VANGL planar cell polarity protein 2
|
|
VASH1
|
vasohibin 1
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VAV3
|
vav 3 guanine nucleotide exchange factor
|
|
VCP
|
valosin containing protein
|
|
VDAC1
|
voltage-dependent anion channel 1
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIM
|
vimentin
|
|
VIPR1
|
vasoactive intestinal peptide receptor 1
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VRK1
|
vaccinia related kinase 1
|
|
VWF
|
von Willebrand factor
|
|
WAPAL
|
wings apart-like homolog (Drosophila)
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WFIKKN2
|
WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2
|
|
WHSC1
|
Wolf-Hirschhorn syndrome candidate 1
|
|
WNK1
|
WNK lysine deficient protein kinase 1
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WRAP53
|
WD repeat containing, antisense to TP53
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XPO1
|
exportin 1
|
|
YBX1
|
Y box binding protein 1
|
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
|
ZIC2
|
Zic family member 2
|
|
ZPBP2
|
zona pellucida binding protein 2
|
